Comparative effectiveness of heterologous booster schedules with AZD1222, BNT162b2, or mRNA-1273 vaccines against COVID-19 during omicron predominance in the Nordic countries

MLA

Niklas Worm Andersson, et al. Comparative Effectiveness of Heterologous Booster Schedules with AZD1222, BNT162b2, or MRNA-1273 Vaccines against COVID-19 during Omicron Predominance in the Nordic Countries. Nov. 2022. EBSCOhost, https://doi.org/10.1101/2022.11.24.22282651.

APA

Niklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, Nicklas Pihlström, Jostein Starrfelt, Kristýna Faksová, Eero Poukka, Lars Christian Lund, Christian Holm Hansen, Mia Aakjær, Jesper Kjær, Catherine Cohet, Mathijs Goossens, Morten Andersen, Jesper Hallas, Hinta Meijerink, Rickard Ljung, & Anders Hviid. (2022). Comparative effectiveness of heterologous booster schedules with AZD1222, BNT162b2, or mRNA-1273 vaccines against COVID-19 during omicron predominance in the Nordic countries. https://doi.org/10.1101/2022.11.24.22282651

Chicago

Niklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, Nicklas Pihlström, Jostein Starrfelt, Kristýna Faksová, Eero Poukka, et al. 2022. “Comparative Effectiveness of Heterologous Booster Schedules with AZD1222, BNT162b2, or MRNA-1273 Vaccines against COVID-19 during Omicron Predominance in the Nordic Countries,” November. doi:10.1101/2022.11.24.22282651.